Oak Therapeutics

Everybody knows someone who has difficulties taking medicines – we are doing something about it with our proprietary drug delivery platform.

  • Stage Full Product Ready
  • Industry Biotechnology
  • Location Lawrence, KS, USA
  • Currency USD
  • Founded June 2014
  • Employees 4
  • Incorporation Type C-corp
  • Website oaktherapeutics.com

Company Summary

Medicines don't work in people who don't take them. Oak Therapeutics increases treatment adherence by reformulating active pharmaceutical ingredients for novel delivery formats that will actually work for patients, especially in pediatrics, geriatrics, and other populations in need of solutions, including veterinary medicine. That's why we have received endorsements from organizations such as the Stop TB Partnership or the TB Alliance!

Team

  • Chief Business Officer

    Gerhard Apfelthaler is a global business development expert and management professor. He has previously worked as a business diplomat for the Austrian government. Gerhard has co-founded AT Consult, a market entry consulting firm with offices in Austria and the United States as well as affiliates in China and India, he is a founding shareholder of CURE Pharmaceutical, and co-founder of Start-Up Kids, a start-up school of children ages 7-14.

  • CEO and Chief Science Officer

    Edward Maliski is an accomplished research scientist with >30 years of experience in the development of pharmaceutical and biotechnology products. He is an executive leader who contributed his expertise to facilitate the transfer of new discoveries into pharmaceutical products for the Sterling Winthrop Research Institute, Glaxo Research Institute, Merck & Co., and Amgen. Additionally, he has worked with several successful start-up companies.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free